Immunomedics (IMMU) Receives US Patent 8,076,140 for Improved Cell Lines for Protein Therapeutic Manufacturing
Go back to Immunomedics (IMMU) Receives US Patent 8,076,140 for Improved Cell Lines for Protein Therapeutic Manufacturing| Immunomedics, Inc. (NASDAQ: IMMU) | Delayed: 87.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.86 | 52 Week High | $5.44 | |||
| Open | $238.99 | 52 Week Low | $1.61 | |||
| Day High | $87.86 | P/E | N/A | |||
| Day Low | $87.86 | EPS | $-0.15 | |||
| Volume | 300,340 | |||||

